Company profile for Niowave

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Niowave was founded in 2005 by former National Superconducting Cyclotron Laboratory researcher, Terry Grimm, and a group of private investors. Niowave is a world-wide leader in research, development, manufacturing and operation of superconducting electron linear accelerators which are used for medical radioisotope production. Niowave received a 2016 Small Business Administration Tibbetts award and was named the 2010 SBIR/STTR...
Niowave was founded in 2005 by former National Superconducting Cyclotron Laboratory researcher, Terry Grimm, and a group of private investors. Niowave is a world-wide leader in research, development, manufacturing and operation of superconducting electron linear accelerators which are used for medical radioisotope production. Niowave received a 2016 Small Business Administration Tibbetts award and was named the 2010 SBIR/STTR Small Business of the Year for the US Department of Energy. Their highly skilled workforce was built by combining the scientific and technical expertise from nearby world-class universities and national laboratories.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1012 N Walnut St. Lansing, MI 48906
Telephone
Telephone
517-999-3475
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

ChemTides

Not Confirmed

envelop Contact Supplier

ChemTides

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/niowave-and-novartis-enter-global-actinium-225-supply-agreement-to-advance-next-generation-cancer-therapies-302684489.html

PR NEWSWIRE
11 Feb 2026

https://www.prnewswire.com/news-releases/niowave-expands-global-supply-agreement-with-astrazeneca-to-deliver-actinium-225-for-next-generation-cancer-therapies-302646279.html

PR NEWSWIRE
18 Dec 2025

ABOUT THIS PAGE

Contact Niowave and get a quotation

Niowave is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of ACTINIUM-225 NITRATE (AC-225) bulk with DMF offered by Niowave

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty